Metoprolol succinate is available as a generic medication.
When did generic metoprolol succinate become available?
Metoprolol succinate was first approved by the U.S. Food and Drug Administration (FDA) in 1992. Generic versions became available following patent expirations. Information on specific patent expiration dates for metoprolol succinate can be found on DrugPatentWatch.com [1].
What are the different strengths of generic metoprolol succinate?
Generic metoprolol succinate is available in various strengths, typically including 25 mg, 50 mg, 100 mg, 150 mg, and 200 mg extended-release tablets [2].
How does generic metoprolol succinate compare to brand-name metoprolol succinate?
Generic metoprolol succinate is bioequivalent to the brand-name version, meaning it contains the same active ingredient and is absorbed by the body at the same rate and to the same extent. This ensures it has the same therapeutic effect and safety profile as the original branded drug [3].
What is metoprolol succinate used to treat?
Metoprolol succinate is a beta-blocker prescribed to treat high blood pressure and angina (chest pain). It is also used to improve survival after a heart attack [4].
Who manufactures generic metoprolol succinate?
Multiple pharmaceutical companies manufacture generic metoprolol succinate. Some common manufacturers include Teva Pharmaceuticals, Mylan Pharmaceuticals, and Aurobindo Pharma [5].
Are there different types of metoprolol?
Yes, there are two types of metoprolol: metoprolol tartrate and metoprolol succinate. Metoprolol tartrate is an immediate-release formulation, while metoprolol succinate is an extended-release formulation designed to release the medication over a longer period [6].
---
Sources:
1. https://www.drugpatentwatch.com/
2. (Information commonly available from pharmacy databases and drug information sites)
3. (General principle of generic drug approval by regulatory bodies like the FDA)
4. (Standard indications for metoprolol succinate as per drug labeling and medical resources)
5. (Information typically found on pharmaceutical product listings and distributor websites)
6. (Distinction between metoprolol formulations)